Herpes encephalitis during natalizumab treatment in multiple sclerosis

被引：25
|
作者：
Kwiatkowski, A. [1 ]
Gallois, J. [1 ]
Bilbault, N. [1 ]
Calais, G. [1 ]
Mackowiak, A. [1 ]
Hautecoeur, P. [1 ]
机构：
[1] Univ Catholique Lille, PRES Lille Nord France, Grp Hosp, Inst Catholique Lille,Fac Libre Med,Clin Neurol, Lille, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 06期
关键词：
acyclovir; encephalitis; herpes simplex; monoclonal antibody; multiple sclerosis; natalizumab; SIMPLEX ENCEPHALITIS;
D O I：
10.1177/1352458511428082
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In this case report we describe the first non-fatal herpes simplex virus encephalitis (HSE) case with natalizumab for multiple sclerosis (MS). A 36-year-old woman, previously treated with immunomodulatory and immunosuppressive drugs for MS, developed acute encephalitis after 6 monthly natalizumab perfusions. Brain imaging demonstrated suggestive bi-temporal lesions. Herpes simplex virus type-1 DNA was detected in cerebrospinal fluid. The patient improved gradually after a 21-day course of intravenous acyclovir, but neuropsychiatric changes remained 5 months later. Our non-fatal case of HSE and other reported cases of herpes infections provide evidence of an increased risk with natalizumab and point to the need for clinicians to maintain awareness.
引用
收藏
页码：909 / 911
页数：3
相关论文
共 50 条
  • [21] Treatment of multiple sclerosis: role of natalizumab
    Comi, Giancarlo
    NEUROLOGICAL SCIENCES, 2009, 30 : 155 - 158
  • [22] Treatment of multiple sclerosis: role of natalizumab
    Giancarlo Comi
    Neurological Sciences, 2009, 30 : 155 - 158
  • [23] Altered lymphocyte profiles and herpes zoster infections in patients with multiple sclerosis on natalizumab
    Balshi, Alexandra
    Manning, Nova
    Dempsey, John
    Kumbar, Sachin
    Baber, Ursela
    Sloane, Jacob A.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (10) : 1239 - +
  • [24] Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis
    Azza Ismail
    Julie Kemp
    Basil Sharrack
    Journal of Neurology, 2009, 256 : 1771 - 1772
  • [25] Natalizumab for the treatment of multiple sclerosis and Crohn's disease
    Keeley, KA
    Rivey, MP
    Allington, DR
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (11) : 1833 - 1843
  • [26] Natalizumab is Effective for the Treatment of Relapsingremitting Tumefactive Multiple Sclerosis
    Nakamura, Masataka
    Itani, Kumi
    Miyake, Kousuke
    Kunieda, Takenobu
    Kaneko, Satoshi
    Kusaka, Hirofumi
    INTERNAL MEDICINE, 2017, 56 (02) : 211 - 214
  • [27] Pharmacotherapy Options for Multiple Sclerosis: Focus on Natalizumab
    Stangel, Martin
    Kieseier, Bernd C.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 947 - 952
  • [28] Natalizumab concentrations during pregnancy in three patients with multiple sclerosis
    Toorop, Alyssa A.
    Rispens, Theo
    Strijbis, Eva M. M.
    van Oosten, Bob W.
    de Jong, Brigit A.
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    van Kempen, Zoe L. E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (02) : 323 - 326
  • [29] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [30] Natalizumab Rebound in Multiple Sclerosis
    Lee, Joshua D.
    Chen, Tychicus
    NEUROHOSPITALIST, 2022, 12 (01) : 197 - 198
12345